Variations in Target Volume Definition for Postoperative Radiotherapy in Stage III Non-Small-Cell Lung Cancer: Analysis of an International Contouring Study

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 4, 2010, Pages 1106-1113

  Spoelstra, Femke O B ^a   Senan, Suresh ^a   Le Péchoux, Cecile ^b   Ishikura, Satoshi ^c   Casas, Francesc ^d   Ball, David ^e   Price, Allan ^f   De Ruysscher, Dirk ^g   van Sörnsen de Koste, John R ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c NATIONAL CANCER CENTER   (Japan)

^d HOSPITAL CLÍNIC   (Spain)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Interobserver variability; Non small cell lung cancer; Postoperative radiotherapy; Resection; Target volumes

Indexed keywords

ADJUVANT RADIOTHERAPY; CLINICAL TARGET VOLUMES; DOSIMETRIC IMPACT; INTERNATIONAL EXPERTS; INTEROBSERVER VARIABILITY; NON SMALL CELL LUNG CANCER; POSTOPERATIVE RADIOTHERAPY; PROSPECTIVE STUDY; RADIATION ONCOLOGISTS; TARGET VOLUMES;

PROGRAM INTERPRETERS; QUALITY ASSURANCE; RADIOTHERAPY; TARGETS; TOTAL QUALITY MANAGEMENT; TOXICITY;

BIOLOGICAL ORGANS;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION FIELD; RADIATION SICKNESS; RADIATION TARGET VOLUME; RADIOTHERAPY CONTOURING; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL PROTOCOLS; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; OBSERVER VARIATION; PNEUMONECTOMY; QUALITY CONTROL; RADIATION ONCOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 77649112719     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.072     Document Type: Article

References (34)

1. Stephens R.J., Girling D.J., Bleehen N.M., et al. The role of post-operative radiotherapy in non-small-cell lung cancer: A multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Br J Cancer 74 (1996) 632-639
2. Mayer R., Smolle-Juettner F.M., Szolar D., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 112 (1997) 954-959
3. Trodella L., Granone P., Valente S., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: Definitive results of a phase III randomized trial. Radiother Oncol 62 (2002) 11-19
4. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 352 (1998) 257-263
5. Machtay M., Lee J.H., Shrager J.B., et al. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol 19 (2001) 3912-3917
6. Miles E.F., Kelsey C.R., Kirkpatrick J.P., et al. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: Calculations from clinical trials. Int J Radiat Oncol Biol Phys 68 (2007) 1047-1052
7. Uno T., Sumi M., Kihara A., et al. Postoperative radiotherapy for non-small-cell lung cancer: Results of the 1999-2001 patterns of care study nationwide process survey in Japan. Lung Cancer 56 (2007) 357-362
8. Lally B.E., Zelterman D., Colasanto J.M., et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 24 (2006) 2998-3006
9. Douillard J.Y., Rosell R., De Lena M., et al. Impact of postoperative radiation therapy on survival in patients with complete resection and Stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 72 (2008) 695-701
10. Le Péchoux C., Dunant A., Pignon J.P., et al. Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement. J Clin Oncol 25 (2007) e10-e11
11. Keller S.M., Adak S., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 343 (2000) 1217-1222
12. van de Steene J., Linthout N., de Mey J., et al. Definition of gross tumor volume in lung cancer: Inter-observer variability. Radiother Oncol 62 (2002) 37-49
13. Senan S., van Sörnsen de Koste J., Samson M., et al. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol 53 (1999) 247-255
14. Bowden P., Fisher R., Mac Manus M., et al. Measurement of lung tumor volumes using three-dimensional computer planning software. Int J Radiat Oncol Biol Phys 53 (2002) 566-573
15. Giraud P., Elles S., Helfre S., et al. Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 62 (2002) 27-36
16. van Sörnsen de Koste J.R., Senan S., Underberg R.W., et al. Use of CD-ROM-based tool for analyzing contouring variations in involved-field radiotherapy for Stage III NSCLC. Int J Radiat Oncol Biol Phys 63 (2005) 334339
17. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
18. Chapet O., Kong F.M., Quint L.E., et al. CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63 (2005) 170-178
19. ICRU report 62: Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU report 50) (1999), International Commission on Radiation Units and Measurements, Bethesda, MD
20. Bonner J.A., and Spencer S.A. Postoperative radiotherapy in non-small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy. J Clin Oncol 24 (2006) 2978-2980
21. Pisters K.M. Adjuvant chemotherapy for non-small-cell lung cancer: The smoke clears. N Engl J Med 352 (2005) 2640-2642
22. Pignon J.P., Tribodet H., Scagliotti G.V., et al. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 26 (2008) 3552-3559
23. Ichinose Y., Kato H., Koike T., et al. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: Questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 34 (2001) 29-36
24. DiBiase S.J., Werner-Wasik M., Croce R., et al. Standard off-cord lung oblique fields do not include the entire mediastinum: A computed tomography simulator study. Am J Clin Oncol 23 (2000) 249-252
25. Yuan S., Sun X., Li M., et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30 (2007) 239-244
26. Senan S., Burgers S., Samson M.J., et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 999-1006
27. Davis J.B., Reiner B., Dusserre A., et al. Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: The dummy run. Radiother Oncol 64 (2002) 65-73
28. Foppiano F., Fiorino C., Frezza G., et al. The impact of contouring uncertainty on rectal 3D dose-volume data: Results of a dummy run in a multicenter trial (AIROPROS01-02). Int J Radiat Oncol Biol Phys 57 (2003) 573-579
29. Seddon B., Bidmead M., Wilson J., et al. Target volume definition in conformal radiotherapy for prostate cancer: Quality assurance in the MRC RT-01 trial. Radiother Oncol 56 (2000) 73-83
30. Widder J., Sedlmayer F., Stanek C., et al. Quality assurance in preoperative radiotherapy of rectal cancer: Evaluation of a pre-trial dummy-run. Radiother Oncol 56 (2000) 341-347
31. Kouloulias V.E., Giraud J.Y., Davis B.J., et al. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: The dummy run. Radiother Oncol 73 (2004) 11-20
32. Coles C.E., Hoole A.C., Harden S.V., et al. Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: Quality assurance for the SIOP PNET 4 trial protocol. Radiother Oncol 69 (2003) 189-194
33. Weiss E., and Hess C.F. The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences. Strahlenther Onkol 179 (2003) 21-30
34. Cooper J.S., Mukherji S.K., Toledano A.Y., et al. An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658). Int J Radiat Oncol Biol Phys 67 (2007) 972-975